GGrantIndex
Sort

326,823 grants matching clinical trial

Development Of Methods For Inducing Solid Organ Transplant Tolerance

$2,145,914
Allan Douglas Kirk · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection

$2,145,755
Anna Wald · University Of Washington · U19 · FY2019 · AI

Subcutaneous Drug Development for Portal Hypertension Ascites

$2,145,275
Gerardo M. Castillo · Pharmain Corporation · R44 · FY2024 · DK

Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial

$2,145,116
David R Boulware · University Of Minnesota · UG3 · FY2023 · NS

Dominantly Inherited Alzheimer Network: Clinical Core

$2,145,092
John Morris · Washington University · U19 · FY2023 · AG

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

$2,145,080
Hugh Sampson · Icahn School Of Medicine At Mount Sinai · UL1 · FY2011 · RR

Cellular and Molecular Geroscience CoBRE: Phase 2

$2,145,000
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2025 · GM

Novel Therapies of Chronic Allograft Dysfunction

$2,144,800
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2009 · AI

Gene Therapy for Leber Congenital Amaurosis

$2,144,684
University Of Florida · U10 · FY2005 · EY

Alzheimer's Disease Research Center at Columbia Univ.

$2,144,602
Michael Shelanski · Columbia University Health Sciences · P50 · FY2007 · AG

A Pilot Electroencephalography (EEG) Study to Evaluate the Effect of CT1812 Treatment on Synaptic Activity in Subjects with Mild to Moderate Alzheimerʼs Disease

$2,144,409
Anthony O Caggiano · Cognition Therapeutics, Inc. · RF1 · FY2022 · AG

Center for American Indian and Rural Health Equity

$2,144,341
Alexandra K Adams · Montana State University - Bozeman · P20 · FY2021 · GM

HIV VACCINE TRIAL CLINICAL UNIT

$2,144,184
Harvard University (Medical School) · U01 · FY2004 · AI

The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer

$2,144,148
Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA

SPORE: Targeted Therapies for Glioma

$2,144,141
Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2014 · CA

Center for Research on Improving the Treatment of Drug Abuse

$2,144,106
Charles P O'Brien · University Of Pennsylvania · P60 · FY2008 · DA

(HVTN) HIV VACCINE TRIAL UNITS

$2,144,081
Johns Hopkins University · U01 · FY2004 · AI

MOTOR-Maternal Oral Therapy to Reduce Obstetric Risk

$2,144,072
Steven Nmn Offenbacher · Univ Of North Carolina Chapel Hill · U01 · FY2006 · DE

Center for Pre-Clinical Cancer Research

$2,144,025
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM

Phase lll Study of the Effects of Selenium on Ademonas

$2,143,895
M. Peter Lance · University Of Arizona · P01 · FY2007 · CA

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,143,865
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA

CANCER CENTER SUPPORT GRANT

$2,143,630
City Of Hope/Beckman Research Institute · P30 · FY2000 · CA

Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD

$2,143,493
Kathleen M Hayden · Wake Forest University Health Sciences · R01 · FY2022 · AG

Steroid Hormone Action In Female Reproduction

$2,143,390
Lynnette K Nieman · Child Health And Human Development · Z01 · FY2007 · HD

Role of Viral Reservoirs in the Pathogenesis of HIV Disease

$2,143,287
Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI